Osciflex

About Osciflex

Osciflex utilizes a biomimetic system that replicates natural processes to prevent venous thromboembolism (VTE) in hospitalized patients. By addressing the high incidence of hospital-associated VTE, which leads to significant complications and costs, Osciflex aims to reduce patient readmission rates and improve overall healthcare outcomes.

```xml <problem> Hospital-associated venous thromboembolism (HA-VTE) is a significant complication for hospitalized patients, leading to increased length of stay, higher inpatient costs, and a substantial risk of readmission. Current methods for VTE prevention may not fully address the underlying physiological mechanisms that contribute to clot formation in at-risk patients. </problem> <solution> Osciflex offers a biomimetic system designed to mimic natural processes within the body to prevent deadly blood clots. By replicating these natural mechanisms, the Osciflex system aims to reduce the incidence of HA-VTE, thereby decreasing patient readmission rates and improving overall healthcare outcomes. The system provides a novel approach to VTE prevention, addressing a critical need in inpatient care. </solution> <features> - Biomimetic technology that replicates natural physiological processes - Designed specifically for the prevention of hospital-associated VTE (HA-VTE) </features> <target_audience> The primary target audience includes hospitals and healthcare systems seeking to reduce VTE incidence and improve patient outcomes. </target_audience> ```

What does Osciflex do?

Osciflex utilizes a biomimetic system that replicates natural processes to prevent venous thromboembolism (VTE) in hospitalized patients. By addressing the high incidence of hospital-associated VTE, which leads to significant complications and costs, Osciflex aims to reduce patient readmission rates and improve overall healthcare outcomes.

Where is Osciflex located?

Osciflex is based in Philadelphia, United States.

When was Osciflex founded?

Osciflex was founded in 2017.

Location
Philadelphia, United States
Founded
2017
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

Osciflex

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Osciflex utilizes a biomimetic system that replicates natural processes to prevent venous thromboembolism (VTE) in hospitalized patients. By addressing the high incidence of hospital-associated VTE, which leads to significant complications and costs, Osciflex aims to reduce patient readmission rates and improve overall healthcare outcomes.

osciflex.com
Founded 2017Philadelphia, United States

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Hospital-associated venous thromboembolism (HA-VTE) is a significant complication for hospitalized patients, leading to increased length of stay, higher inpatient costs, and a substantial risk of readmission. Current methods for VTE prevention may not fully address the underlying physiological mechanisms that contribute to clot formation in at-risk patients.

Solution

Osciflex offers a biomimetic system designed to mimic natural processes within the body to prevent deadly blood clots. By replicating these natural mechanisms, the Osciflex system aims to reduce the incidence of HA-VTE, thereby decreasing patient readmission rates and improving overall healthcare outcomes. The system provides a novel approach to VTE prevention, addressing a critical need in inpatient care.

Features

Biomimetic technology that replicates natural physiological processes

Designed specifically for the prevention of hospital-associated VTE (HA-VTE)

Target Audience

The primary target audience includes hospitals and healthcare systems seeking to reduce VTE incidence and improve patient outcomes.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.